Jamaica's first medical ganja company launched

Warning message

The subscription service is currently unavailable. Please try again later.

Professor Henry Lowe yesterday launched Jamaica’s first medical ganja company, MediCanja in Kingston, to capitalise on the multibillion-dollar industry’s commercialisation.

Lowe is the executive chairman of Biotech Research and Development Institute.

He said it would be unfortunate if Jamaica lost out to a booming multibillion-dollar industry in Europe, Canada and the United States.

He noted that Canada’s hemp industry is valued at more than US$2 billion yearly.

Professor Lowe pointed out that Jamaica was the first country in the world to develop a commercial product from ganja, Canasol used to treat glaucoma.

MediCanja will undertake pioneering research and product development using the medicinal compounds called the CBDs – the non-psychoactive compounds in ganja.

The establishment of MediCanja follows the publication of a findings from a survey, which showed that a majority of Jamaica’s population may be in support of relaxing the laws prohibiting the use of marijuana.

The survey, which...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://jamaica-gleaner.com/latest/article.php?id=49710